Critical Therapeutics, Inc.'s Study Suggests Steroid-Sparing Effect Of ZYFLO(R) In Patients With Severe Asthma

Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced the publication of a scientific poster demonstrating that asthma patients received comparable benefit from a low dose inhaled corticosteroid when taken in combination with ZYFLO(R) (zileuton tablets) compared to a higher dose of inhaled corticosteroid alone.

MORE ON THIS TOPIC